Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sameer Alharthi"'
Autor:
Doaa Anbarserry, Mahmoud Mosli, Yousef Qari, Omar Saadah, Rana Bokhary, Ahmed Esmat, Mohammed Alsieni, Ahmed Shaker, Ramu Elango, Sameer Alharthi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Vedolizumab is a humanized monoclonal antibody used to treat moderate-to-severe inflammatory bowel disease (IBD). The aim of the study was to assess the effectiveness of the induction of vedolizumab trough level in predicting short-term (wee
Externí odkaz:
https://doaj.org/article/58be7580eb9847e5a56698cd82e263cc
Autor:
Adriana Buskin, Lili Zhu, Valeria Chichagova, Basudha Basu, Sina Mozaffari-Jovin, David Dolan, Alastair Droop, Joseph Collin, Revital Bronstein, Sudeep Mehrotra, Michael Farkas, Gerrit Hilgen, Kathryn White, Kuan-Ting Pan, Achim Treumann, Dean Hallam, Katarzyna Bialas, Git Chung, Carla Mellough, Yuchun Ding, Natalio Krasnogor, Stefan Przyborski, Simon Zwolinski, Jumana Al-Aama, Sameer Alharthi, Yaobo Xu, Gabrielle Wheway, Katarzyna Szymanska, Martin McKibbin, Chris F. Inglehearn, David J. Elliott, Susan Lindsay, Robin R. Ali, David H. Steel, Lyle Armstrong, Evelyne Sernagor, Henning Urlaub, Eric Pierce, Reinhard Lührmann, Sushma-Nagaraja Grellscheid, Colin A. Johnson, Majlinda Lako
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-19 (2018)
Mutations in pre-mRNA processing factors cause autosomal dominant retinitis pigmentosa. Here the authors provide insights into the pathophysiological mechanisms underlying non-syndromic retinal disease caused by heterozygous mutations in genes encodi
Externí odkaz:
https://doaj.org/article/39722a7de98941cab07e48fc0b8400de
The authors have withdrawn this preprint from Research Square
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eeec7e57abfa3c62751dc56d185e6b0
https://doi.org/10.21203/rs.2.14471/v2
https://doi.org/10.21203/rs.2.14471/v2
Autor:
Adriana Buskin, Lili Zhu, Valeria Chichagova, Basudha Basu, Sina Mozaffari-Jovin, David Dolan, Alastair Droop, Joseph Collin, Revital Bronstein, Sudeep Mehrotra, Michael Farkas, Gerrit Hilgen, Kathryn White, Dean Hallam, Katarzyna Bialas, Git Chung, Carla Mellough, Yuchun Ding, Natalio Krasnogor, Stefan Przyborski, Jumana Al-Aama, Sameer Alharthi, Yaobo Xu, Gabrielle Wheway, Katarzyna Szymanska, Martin McKibbin, Chris F Inglehearn, David J Elliott, Susan Lindsay, Robin R Ali, David H Steel, Lyle Armstrong, Evelyne Sernagor, Eric Pierce, Reinhard Lüehrmann, Sushma-Nagaraja Grellscheid, Colin A Johnson, Majlinda Lako
SummaryMutations in pre-mRNA processing factors (PRPFs) cause 40% of autosomal dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed PRPFs cause retinal disease. To understand the molecular basis of this phenot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3576fd9a8e320b379f3a6a5616bf33
Autor:
Dean, Hallam, Joseph, Collin, Sanja, Bojic, Valeria, Chichagova, Adriana, Buskin, Yaobo, Xu, Lucia, Lafage, Elsje G, Otten, George, Anyfantis, Carla, Mellough, Stefan, Przyborski, Sameer, Alharthi, Viktor, Korolchuk, Andrew, Lotery, Gabriele, Saretzki, Martin, McKibbin, Lyle, Armstrong, David, Steel, David, Kavanagh, Majlinda, Lako
Publikováno v:
Stem cells (Dayton, Ohio). 35(11)
Age-related macular degeneration (AMD) is the most common cause of blindness, accounting for 8.7% of all blindness globally. Vision loss is caused ultimately by apoptosis of the retinal pigment epithelium (RPE) and overlying photoreceptors. Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce60341171aa0453c55bfa68159bdc5f
https://pubmed.ncbi.nlm.nih.gov/29596737
https://pubmed.ncbi.nlm.nih.gov/29596737